Ganjiaxin tablets
A technology of Xin tablet and weight, applied in the directions of plant raw materials, pill delivery, digestive system, etc., can solve the problems of different effects and low therapeutic effect, and achieve the effect of proper compatibility, reasonable formula and exact boil effect.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0014] Example 1: Ganjiaxin Tablets
[0015] Ganjiaxin tablets consist of 317.5g schisandra chinensis, 300g Bupleurum chinensis, 300g capillary root, 300g banlangen, 20g intracellular glycopeptide of versicolor versicolor, 20g pig gall powder, 100g starch, and 3.5g magnesium stearate, making 1000 tablets.
experiment example 1
[0016] Experimental Example 1: Clinical Report
[0017] Summary
[0018] Liver depression and spleen deficiency syndrome is the most common syndrome of spleen-stomach disease. The reason is that the liver and spleen are out of balance, and the liver fails to ventilate, which in turn affects the spleen's transportation and chemical function or causes the spleen to be weak, and the biochemistry of qi and blood has no source, resulting in liver blood Not enough to nourish the liver. The liver loses its place to support, and the Qi stagnation stagnates. Clinically, there are often syndromes of stagnation of liver qi and weakness of spleen qi. In this experiment, according to the standard of TCM dialectics, the clinical research and evaluation of Ganjiaxin Tablets was carried out on patients with stagnation of liver qi and weakness of spleen qi according to the treatment plan. At the same time, combined with the observation of changes in its liver function and hepatitis B virus ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com